JAK2 INHIBITORS AND METHODS OF USE THEREOF

The present disclosure relates to novel compounds and pharmaceutical compositions thereof, and methods for inhibiting the activity of JAK2 enzymes with the compounds and compositions of the disclosure. The present disclosure further relates to, but is not limited to, methods for treating disorders a...

Full description

Saved in:
Bibliographic Details
Main Authors DIPIETRO, Lucian V, FRIDRICH, Cary Griffin, TAYLOR, Alexander M, BOEZIO, Alessandro, MCCLEAN, Thomas H, THOMSON, Christopher, SWETT, Rebecca Jane, MADEC, Amael, KURUKULASURIYA, Ravi, EVANS, Catherine A
Format Patent
LanguageEnglish
French
Published 02.03.2023
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:The present disclosure relates to novel compounds and pharmaceutical compositions thereof, and methods for inhibiting the activity of JAK2 enzymes with the compounds and compositions of the disclosure. The present disclosure further relates to, but is not limited to, methods for treating disorders associated with JAK2 signaling with the compounds and compositions of the disclosure. La présente invention concerne de nouveaux composés et des compositions pharmaceutiques de ceux-ci, et des méthodes d'inhibition de l'activité d'enzymes JAK2 avec les composés et les compositions de l'invention. La présente invention concerne en outre, mais sans s'y limiter, des méthodes de traitement de troubles associés à la signalisation JAK2 avec les composés et les compositions de l'invention.
Bibliography:Application Number: WO2022US40835